/Bio-Rad%20Laboratories%20Inc_%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
With a market cap of $9.5 billion, Bio-Rad Laboratories, Inc. (BIO) operates in the healthcare and life sciences industry. The Hercules, California-based company develops and manufactures a wide range of clinical diagnostics and life science research products, serving markets such as biopharmaceuticals, genomics, proteomics, and food safety.
Companies valued at less than $10 billion are generally considered “mid-cap” stocks and Bio-Rad Laboratories fits this criterion perfectly. Bio-Rad Laboratories is renowned for its pioneering Digital Droplet technology, which offers unmatched precision and sensitivity in quantifying DNA and RNA molecules, setting it apart in both life science research and clinical diagnostics.